2022年，全球抗癌新药井喷上市，多款重磅创新药获批。求臻医学根据美国食品药品监督管理局（FDA）公布信息、中国国家药品监督管理局（NMPA）发布的药品批准证明文件，以及各公司的公开信息，为大家整理了2022年FDA/NMPA获批的抗肿瘤药物。
该盘点共涉及64种药物，涵盖了实体瘤、非小细胞肺癌、小细胞肺癌、乳腺癌、食管癌、胃或胃食管交界处腺癌、胆管癌、甲状腺癌、鼻咽癌、头颈癌、宫颈癌、前列腺癌、肝细胞癌、黑色素瘤、尿路上皮癌、膀胱癌、卵巢癌、神经母细胞瘤、子宫内膜癌、炎性肌纤维母细胞瘤（IMT）、腺泡状软组织肉瘤。
注：内容整理自网络可查的公开信息，部分已获批的仿制药/生物类似药在本文中未列出。
数据来源：
[1] https://www.fda.gov/drugs/resources-information-approved-drugs.
[2] 中国国家药监局药品批准证明文件待领取信息. https://www.nmpa.gov.cn/zwfw/zwfwpjfbzs/pjfbzsyp/index.html.
[3] https://www.sohu.com/a/529093796_121123708
[4] http://www.100pei.com/13319.html
[5] https://www.163.com/dy/article/HDETALBH05349C3I.html
[6] https://www.cn-healthcare.com/articlewm/20221009/content-1447122.html
[7] http://www.100pei.com/7190.html
[8] https://www.163.com/dy/article/HP4NLNBL05349C3G.html
[9] https://www.cn-healthcare.com/articlewm/20221129/content-1475037.html
[10] https://www.xinyao.com.cn/other-newdrug/202203291648540649.htm
[11] https://mp.weixin.qq.com/s/GAViuwgBB094DDneld5yiw
[12] https://mp.weixin.qq.com/s/vAeEMpTWilJdBuPWCcUKlQ
[13] https://www.headkonmed.com/headkonmed/vip_doc/24384977.html
[14] https://www.cn-healthcare.com/articlewm/20220922/content-1439063.html
[15] https://www.cn-healthcare.com/articlewm/20221010/content-1447589.html
[16] https://tumormed.com/aizhengzhiliao/4528.html
[17] https://www.163.com/dy/article/HCBG9VVE0514ADIU.html
[18] http://fang.jiangyaojia.com/2096.html
[19] https://www.360kuai.com/pc/92edbeca670981317?cota=3&kuai_so=1&sign=360_57c3bbd1&refer_scene=so_1
[20] https://www.kangbixing.com/tumour/109789.html
[21] https://mp.weixin.qq.com/s/Y4UZo7WlghqqfS2kMHP0iQ
[22] http://www.100pei.com/13198.html
[23] http://www.100pei.com/14102.html
[24] https://xueqiu.com/9835549519/232245850
[25] https://xueqiu.com/9650090648/231856900
[26] http://www.globecancer.com/azzx/show.php?itemid=14768
[27] http://www.100pei.com/14860.html
